La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Harbin Pharmaceutical Group Bilan de santé
Santé financière contrôle des critères 5/6
Harbin Pharmaceutical Group has a total shareholder equity of CN¥5.6B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 35.3%. Its total assets and total liabilities are CN¥14.1B and CN¥8.5B respectively. Harbin Pharmaceutical Group's EBIT is CN¥648.1M making its interest coverage ratio 1088.6. It has cash and short-term investments of CN¥2.8B.
Informations clés
35.3%
Ratio d'endettement
CN¥1.98b
Dette
| Ratio de couverture des intérêts | 1088.6x |
| Argent liquide | CN¥2.85b |
| Fonds propres | CN¥5.61b |
| Total du passif | CN¥8.53b |
| Total des actifs | CN¥14.15b |
Mises à jour récentes de la santé financière
Analyse de la situation financière
Passif à court terme: 600664's short term assets (CN¥10.5B) exceed its short term liabilities (CN¥8.1B).
Passif à long terme: 600664's short term assets (CN¥10.5B) exceed its long term liabilities (CN¥439.0M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 600664 has more cash than its total debt.
Réduire la dette: 600664's debt to equity ratio has increased from 6.3% to 35.3% over the past 5 years.
Couverture de la dette: 600664's debt is well covered by operating cash flow (25.1%).
Couverture des intérêts: 600664's interest payments on its debt are well covered by EBIT (1088.6x coverage).